|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
DE3681787D1
(de)
|
1985-07-05 |
1991-11-07 |
Whitehead Biomedical Inst |
Expression von fremdem genetischem material in epithelzellen.
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
HK1008049A1
(en)
|
1987-09-11 |
1999-04-30 |
Whitehead Institute For Biomedical Research |
Transduced fibroblasts and use therefor
|
|
ATE110108T1
(de)
|
1987-12-11 |
1994-09-15 |
Whitehead Biomedical Inst |
Genetische modifizierung von endothelialen zellen.
|
|
DE68927996T2
(de)
|
1988-02-05 |
1997-12-04 |
Hughes Howard Med Inst |
Modifizierte hepatozyten und deren anwendung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
DE69123981T3
(de)
|
1990-10-31 |
2006-06-14 |
Cell Genesys Inc |
Nützliche retrovirale vektoren für die gentherapie
|
|
SE9201984D0
(sv)
|
1992-06-29 |
1992-06-29 |
Pharmacia Biosensor Ab |
Improvement in optical assays
|
|
DE69334275D1
(de)
|
1992-08-21 |
2009-05-20 |
Univ Bruxelles |
Immunoglobuline ohne Leichtkette
|
|
US5308341A
(en)
|
1993-09-28 |
1994-05-03 |
Becton, Dickinson And Company |
Method of testing the dose accuracy of a medication delivery device
|
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
|
US6302855B1
(en)
|
1998-05-20 |
2001-10-16 |
Novo Nordisk A/S |
Medical apparatus for use by a patient for medical self treatment of diabetes
|
|
US6192891B1
(en)
|
1999-04-26 |
2001-02-27 |
Becton Dickinson And Company |
Integrated system including medication delivery pen, blood monitoring device, and lancer
|
|
US6277099B1
(en)
|
1999-08-06 |
2001-08-21 |
Becton, Dickinson And Company |
Medication delivery pen
|
|
JP4383168B2
(ja)
|
2001-09-12 |
2009-12-16 |
ベクトン・ディキンソン・アンド・カンパニー |
マイクロ針投与デバイスおよび薬物投与デバイス
|
|
FR2849436B1
(fr)
|
2002-12-27 |
2007-01-05 |
Patrick Frayssinet |
Particules et ceramiques de phosphates de calcium pour transfection in vivo et in vitro
|
|
US9409950B2
(en)
|
2010-12-23 |
2016-08-09 |
Biogen Ma Inc. |
Linker peptides and polypeptides comprising same
|
|
US9163090B2
(en)
*
|
2012-05-07 |
2015-10-20 |
Cellerant Therapeutics, Inc. |
Antibodies specific for CLL-1
|
|
BR112017000939A2
(pt)
*
|
2014-07-21 |
2017-11-14 |
Novartis Ag |
tratamento de câncer usando um receptor antigênico quimérico de cll-1
|
|
MA40579A
(fr)
*
|
2014-09-12 |
2016-03-17 |
Genentech Inc |
Anticorps anti-cll-1 et immunoconjugués
|
|
EP3250602A1
(en)
|
2015-01-26 |
2017-12-06 |
Cellectis |
T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm
|
|
IL258491B2
(en)
|
2015-10-16 |
2023-09-01 |
Univ Columbia |
Preparations and methods for inhibiting antigens of a particular lineage
|
|
MA43134A
(fr)
|
2015-10-30 |
2018-09-05 |
Aleta Biotherapeutics Inc |
Compositions et méthodes de transduction tumorale
|
|
WO2017075537A1
(en)
|
2015-10-30 |
2017-05-04 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
EP3585817A4
(en)
|
2017-02-22 |
2020-12-02 |
Aleta Biotherapeutics Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
|
WO2018156791A1
(en)
|
2017-02-22 |
2018-08-30 |
Aleta Biotherapeutics Inc. |
Compositions and methods for tumor transduction
|
|
CA3110837A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma Inc. |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
WO2020052543A1
(en)
*
|
2018-09-10 |
2020-03-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against cd33 and constructs thereof
|
|
WO2020113063A1
(en)
*
|
2018-11-30 |
2020-06-04 |
Aleta Biotherapeutics Inc. |
Single domain antibodies against cll-1
|
|
AU2020338011A1
(en)
|
2019-08-28 |
2022-03-10 |
Vor Biopharma Inc. |
Compositions and methods for CLL1 modification
|
|
AU2021268340A1
(en)
*
|
2020-05-06 |
2022-12-08 |
Dragonfly Therapeutics, Inc. |
Proteins binding NKG2D, CD16 and CLEC12A
|
|
EP4204565A1
(en)
|
2020-08-28 |
2023-07-05 |
Vor Biopharma Inc. |
Compositions and methods for cll1 modification
|
|
EP4204564A1
(en)
|
2020-08-28 |
2023-07-05 |
Vor Biopharma Inc. |
Compositions and methods for cd123 modification
|
|
CN113045658B
(zh)
*
|
2020-12-11 |
2021-12-24 |
广州百暨基因科技有限公司 |
抗cll1抗体及其应用
|